|
1
|
Green DA, Rink M, Xylinas E, Matin SF,
Stenzl A, Roupret M, Karakiewicz PI, Scherr DS and Shariat SF:
Urothelial carcinoma of the bladder and the upper tract: Disparate
twins. J Urol. 189:1214–1221. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rouprêt M, Zigeuner R, Palou J, Boehle A,
Kaasinen E, Sylvester R, Babjuk M and Oosterlinck W: European
guidelines for the diagnosis and management of upper urinary tract
urothelial cell carcinomas: 2011 update. Eur Urol. 59:584–594.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rouprêt M, Babjuk M, Compérat E, Zigeuner
RJ, Sylvester RJ, Burger M, Cowan NC, Böhle A, Van Rhijn BW,
Kaasinen E, et al: European association of urology guidelines on
upper urinary tract urothelial cell carcinoma: 2015 update. Eur
Urol. 68:868–879. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Terakawa T, Miyake H, Muramaki M, Takenaka
A, Hara I and Fujisawa M: Risk factors for intravesical recurrence
after surgical management of transitional cell carcinoma of the
upper urinary tract. Urology. 71:123–127. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Novara G, De Marco V, Dalpiaz O, Galfano
A, Bouygues V, Gardiman M, Martignoni G, Patard JJ, Artibani W and
Ficarra V: Independent predictors of contralateral metachronous
upper urinary tract transitional cell carcinoma after
nephroureterectomy: Multi-institutional dataset from three European
centers. Int J Urol. 16:187–191. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xylinas E, Kluth L, Passoni N, Trinh QD,
Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, et
al: Prediction of intravesical recurrence after radical
nephroureterectomy: Development of a clinical decision-making tool.
Eur Urol. 65:650–658. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Seisen T, Granger B, Colin P, Leon P,
Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat
SF and Rouprêt M: A systematic review and meta-analysis of
clinicopathologic factors linked to intravesical recurrence after
radical nephroureterectomy to treat upper tract urothelial
carcinoma. Eur Urol. 67:1122–1133. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lowrance WT, Ordoñez J, Udaltsova N, Russo
P and Go AS: CKD and the risk of incident cancer. J Am Soc Nephrol.
25:2327–2334. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chung SD, Huang KH, Lai MK, Huang CY, Chen
CH, Pu YS, Yu HJ and Chueh SC: CKD as a risk factor for bladder
recurrence after nephroureterectomy for upper urinary tract
urothelial carcinoma. Am J Kidney Dis. 50:743–753. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li CE, Chien CS, Chuang YC, Chang YI, Tang
HP and Kang CH: Chronic kidney disease as an important risk factor
for tumor recurrences, progression and overall survival in primary
non-muscle-invasive bladder cancer. Int Urol Nephrol. 48:993–999.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Oberg BP, McMenamin E, Lucas FL, McMonagle
E, Morrow J, Ikizler TA and Himmelfarb J: Increased prevalence of
oxidant stress and inflammation in patients with moderate to severe
chronic kidney disease. Kidney Int. 65:1009–1016. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rausch S, Hennenlotter J, Todenhöfer T,
Aufderklamm S, Schwentner C, Sievert KD, Stenzl A and Gakis G:
Impaired estimated glomerular filtration rate is a significant
predictor for non-muscle-invasive bladder cancer recurrence and
progression-introducing a novel prognostic model for bladder cancer
recurrence. Urol Oncol. 32:1178–1183. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marchioni M, Cindolo L, Autorino R,
Primiceri G, Arcaniolo D, De Sio M and Schips L: High
Neutrophil-to-lymphocyte Ratio as Prognostic Factor in patients
affected by upper tract urothelial cancer: A systematic review and
meta-analysis. Clin Genitourin Cancer. 15:343–349.e1.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106(dju124)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kishimoto N, Takao T, Kuribayashi S,
Yamamichi G, Nakano K, Kawamura M, Tsutahara K, Tanigawa G and
Yamaguchi S: The neutrophil-to-lymphocyte ratio as a predictor of
intravesical recurrence in patients with upper urinary tract
urothelial carcinoma treated with radical nephroureterectomy. Int J
Clin Oncol. 22:153–158. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yoshitomi R, Nakayama M, Sakoh T, Fukui A,
Katafuchi E, Seki M, Tsuda S, Nakano T, Tsuruya K and Kitazono T:
High neutrophil/lymphocyte ratio is associated with poor renal
outcomes in Japanese patients with chronic kidney disease. Ren
Fail. 41:238–243. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Eble JN, Sauter G, Epstein JI and
Sesterhenn IA (eds): World Health Organisation Classification of
Tumours. Pathology and genetics of tumours of the urinary system
and male genital organs. IARC Press, Lyon, 2004.
|
|
18
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A (eds): AJCC cancer staging manual (7th
edition). New York, NY, Springer, 2010.
|
|
19
|
Levey AS, Bosch JP, Lewis JB, Greene T,
Rogers N and Roth D: A more accurate method to estimate glomerular
filtration rate from serum creatinine: A new prediction equation.
Modification of diet in renal disease study group. Ann Intern Med.
130:461–470. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xylinas E, Rink M, Margulis V, Karakiewicz
P, Novara G and Shariat SF: Upper Tract Urothelial Carcinoma
Collaboration (UTUCC). Multifocal carcinoma in situ of the upper
tract is associated with high risk of bladder cancer recurrence.
Eur Urol. 61:1069–1070. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kates M, Badalato GM, Gupta M and
McKiernan JM: Secondary bladder cancer after upper tract urothelial
carcinoma in the US population. BJU Int. 110:1325–1329.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ohno Y, Nakashima J, Ohori M, Hatano T and
Tachibana M: Pretreatment neutrophil-to-lymphocyte ratio as an
independent predictor of recurrence in patients with nonmetastatic
renal cell carcinoma. J Urol. 184:873–848. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Imtiaz F, Shafique K, Mirza SS, Ayoob Z,
Vart P and Rao S: Neutrophil lymphocyte ratio as a measure of
systemic inflammation in prevalent chronic diseases in Asian
population. Int Arch Med. 5(2)2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Candido J and Hagemann T: Cancer-related
inflammation. J Clin Immunol. 33 (Suppl 1):S79–S84. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Azuma T, Matayoshi Y, Odani K, Sato Y,
Sato Y, Nagase Y and Oshi M: Preoperative neutrophil-lymphocyte
ratio as an independent prognostic marker for patients with upper
urinary tract urothelial carcinoma. Clin Genitourin Cancer.
11:337–341. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Momota M, Hatakeyama S, Tokui N, Sato T,
Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie
T, et al: The impact of preoperative severe renal insufficiency on
poor postsurgical oncological prognosis in patients with urothelial
carcinoma. Eur Urol Focus. 5:1066–1073. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Panieri E and Santoro MM: ROS homeostasis
and metabolism: A dangerous liason in cancer cells. Cell Death Dis.
7(e2253)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Vamvakasa S, Bahnerb U and Heidlandb A:
Cancer in end-stage renal disease: Potential factors
involved-editorial-. Am J Nephrol. 18:89–95. 1998.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hafner C, Knuechel R, Zanardo L, Dietmaier
W, Blaszyk H, Cheville J, Hofstaedter F and Hartmann A: Evidence
for oligoclonality and tumor spread by intraluminal seeding in
multifocal urothelial carcinomas of the upper and lower urinary
tract. Oncogene. 20:4910–4915. 2001.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yamashita S, Ito A, Mitsuzuka K, Tochigi
T, Namima T, Soma F, Aizawa M, Ioritani N, Kaiho Y and Arai Y:
Clinical implications of intravesical recurrence after radical
nephroureterectomy for upper urinary tract urothelial carcinoma.
Int J Urol. 23:378–384. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Harris AL and Neal DE: Bladder
cancer-field versus clonal origin. N Engl J Med. 326:759–761.
1992.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wu L, Saxena S, Awaji M and Singh RK:
Tumor-associated neutrophils in cancer: Going Pro. Cancers (Basel).
11(564)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fogar P, Sperti C, Basso D, Sanzari MC,
Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, et
al: Decreased total lymphocyte counts in pancreatic cancer: An
index of adverse outcome. Pancreas. 32:22–28. 2006.PubMed/NCBI View Article : Google Scholar
|
